Construction begins on Jack and Sheryl Morris Cancer Center, New Jersey

Home » News » Construction begins on Jack and Sheryl Morris Cancer Center, New Jersey

Construction has begun on the Jack and Sheryl Morris Cancer Center in New Brunswick, New Jersey. The 12-story building will be jointly operated by Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. The center will be named the Jack and Sheryl Morris Cancer Center after the philanthropist Jack Morris and his wife. This is part of RWJ Barnabas’ mission to compete with the Memorial Sloan Kettering, which has satellite campuses across New Jersey, and the John Theurer Cancer Center, operated by Hackensack Meridian in North Jersey. Rutgers University also seeks to become a national leader in cancer treatment and research.

Also Read: Construction loan secured for New Jersey Mixed-use development

The Jack and Sheryl Morris Cancer Center will be a 12-story, 510-thousand-square-foot building and will be connected to the existing Robert Wood Johnson University Hospital. It will be located at 165 Somerset Street in New Brunswick and is expected to open for operation in 2024. In total, it will cost US$750 million to build the Jack and Sheryl Morris Cancer Center. It will offer inpatient and outpatient cancer treatment; the building will also house labs as it aims to be a worldwide hub for cancer research. Rutgers medical students will work in the building when it opens.

“The next stage of the war on cancer will be waged right here in New Brunswick. Cancer has touched each and every one of us in different ways. This new state-of-the-art cancer center arms us with the science, medicine, and critical resources to fight back like never before and gives new hope to thousands of current cancer patients and to those who have yet to be diagnosed,” said New Brunswick Mayor James Cahill. “Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health already serves as a destination for advanced cancer treatments including clinical trials, stem cell transplantation, proton therapy, and CAR T-cell therapy,” said RWJBarnabas Health CEO Barry Ostrowsky.

83